AbstractBackgroundNontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patients but their epidemiology is not well described.MethodsIn this retrospective observational study we identified all Scandinavian CF patients with a positive NTM culture from airway secretions from 2000 to the end of 2012 and used national CF databases to describe microbiological and clinical characteristics.ResultsDuring the 13-year period 157 (11%) CF patients were culture positive for NTM at least once. Mycobacterium abscessus complex (MABSC) (45%) and Mycobacterium avium complex (MAC) (32%) were the predominant species with geographical differences in distribution. Younger patients were more prone to MABSC (p<0.01). Despite treatment, ...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...
Background: Nontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patient...
Background: Nontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patient...
AbstractBackgroundNontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) p...
Nontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patients but their ...
Background: Infection by nontuberculous mycobacteria (NTM) in patients with cystic fibrosis (CF) is ...
AbstractBackgroundInfection by nontuberculous mycobacteria (NTM) in patients with cystic fibrosis (C...
We performed a multicenter prevalence study of nontuberculous mycobacteria (NTM) involving 1,582 pat...
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistic, difficult to treat pathogens. With ...
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistic, difficult to treat pathogens. With ...
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistic, difficult to treat pathogens. With ...
Abstract Background Nontuberculous mycobacteria (NTM) infections in patients with cystic fibrosis (C...
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistic, difficult to treat pathogens. With ...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...
Background: Nontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patient...
Background: Nontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patient...
AbstractBackgroundNontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) p...
Nontuberculous mycobacteria (NTM) are an emerging threat to cystic fibrosis (CF) patients but their ...
Background: Infection by nontuberculous mycobacteria (NTM) in patients with cystic fibrosis (CF) is ...
AbstractBackgroundInfection by nontuberculous mycobacteria (NTM) in patients with cystic fibrosis (C...
We performed a multicenter prevalence study of nontuberculous mycobacteria (NTM) involving 1,582 pat...
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistic, difficult to treat pathogens. With ...
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistic, difficult to treat pathogens. With ...
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistic, difficult to treat pathogens. With ...
Abstract Background Nontuberculous mycobacteria (NTM) infections in patients with cystic fibrosis (C...
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistic, difficult to treat pathogens. With ...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...
International audienceWe performed a multicenter prevalence study of nontuberculous mycobacteria (NT...